Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre

被引:33
作者
Tveiten, A. [1 ]
Mygland, A. [1 ,3 ,4 ]
Ljostad, U. [1 ]
Thomassen, L. [2 ]
机构
[1] Sorlandet Sykehus Kristiansand, Dept Neurol, N-4604 Kristiansand, Norway
[2] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway
[3] Univ Bergen, Inst Clin Med, Bergen, Norway
[4] Rikshosp Univ Hosp, Hosp Rehabil, Kristiansand, Norway
关键词
TIME WINDOW;
D O I
10.1136/emj.2008.063610
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Aim: To evaluate hospital delays in thrombolytic treatment before and after organisational changes and community-based treatment rates in a previously inexperienced centre. Methods: The delays before and after organisational changes made in 2006 were compared using a prospective treatment database. In a 6-month period in 2007, a community-based search was performed for all hospitalisations for ischaemic stroke. The number of patients admitted within the 0-3 h time window and the proportion treated with tissue plasminogen activator were analysed. Results: The number of treatments increased fourfold from 2005 to 2007 with a significant reduction in mean door-to-needle time from 60 min to 38 min (p=0.002). In the community-based series, 14/137 patients (10%) hospitalised with ischaemic stroke and 13/32 patients (41%) admitted in the 0-3 h window were treated. Conclusions: An inexperienced stroke centre can rapidly implement the necessary logistics to deliver thrombolysis to a large proportion of patients with acute stroke with short hospital delays. Important factors are probably prenotification of a team and the initiation of thrombolytic treatment in the emergency room.
引用
收藏
页码:324 / 326
页数:3
相关论文
共 6 条
[1]   Early intravenous thrombolysis for acute ischemic stroke in a community-based approach [J].
Grond, M ;
Stenzel, C ;
Schmülling, S ;
Rudolf, J ;
Neveling, M ;
Lechleuthner, A ;
Schneweis, S ;
Heiss, WD .
STROKE, 1998, 29 (08) :1544-1549
[2]   Intravenous tissue-type plasminogen activator therapy for ischemic stroke - Houston experience 1996 to 2000 [J].
Grotta, JC ;
Burgin, WS ;
El-Mitwalli, A ;
Long, M ;
Campbell, M ;
Morgenstern, LB ;
Malkoff, M ;
Alexandrov, AV .
ARCHIVES OF NEUROLOGY, 2001, 58 (12) :2009-2013
[3]   Door to thrombolysis:: ER reorganization and reduced delays to acute stroke treatment [J].
Lindsberg, P. J. ;
Haeppoelae, O. ;
Kallela, M. ;
Valanne, L. ;
Kuisma, M. ;
Kaste, M. .
NEUROLOGY, 2006, 67 (02) :334-336
[4]   Population-based analysis of the impact of expanding the time window for acute stroke treatment [J].
Majersik, Jennifer Juhl ;
Smith, Melinda A. ;
Zahuranec, Darin B. ;
Sanchez, Brisa N. ;
Morgenstern, Lewis B. .
STROKE, 2007, 38 (12) :3213-3217
[5]   The yield of expanding the therapeutic time window for tPA [J].
Owe, J. F. ;
Sanaker, P. S. ;
Naess, H. ;
Thomassen, L. .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (05) :354-357
[6]   Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST):: an observational study [J].
Wahlgren, Nils ;
Ahmed, Niaz ;
Davalos, Antoni ;
Ford, Gary A. ;
Grond, Martin ;
Hacke, Werner ;
Hennerici, Michael G. ;
Kaste, Markku ;
Kuelkens, Sonja ;
Larrue, Vincent ;
Lees, Kennedy R. ;
Roine, Risto O. ;
Soinne, Lauri ;
Toni, Danilo ;
Vanhooren, Geert .
LANCET, 2007, 369 (9558) :275-282